Message from our Chairperson
Vital Strategies’ work is critical for these times. While Vital continues to respond to the COVID pandemic, we take a long view on health that is rooted in questions like: How can we ensure that leaders have the right information they need to make decisions? How can we build public trust and support for policies that we know improve health? How can civil society contribute to needed policy changes? How can we work in a coordinated way with cities and countries to help them learn from each other’s mistakes and successes? And seeking answers and solutions to these kinds of questions are at the heart of what Vital brings to its collaborations with leaders around the globe.
Vital works in local partnership in more than 70 countries and brings our voice and experience to global health policymaking arenas. We focus on five areas: noncommunicable diseases, urban health, environmental health and climate change, injury prevention and public health systems strengthening. Layered on this is a commitment to equity and seeking out those who have been historically underserved.
The Vital Strategies Board of Trustees appreciates the organization’s continued commitment to diversity, equity and inclusion in all aspects of its operations and governance. In keeping with our mission, we recognize diversity, equity and inclusion not only as important social goals but also as an important public health issue.
I could not be prouder to be a part of an organization with the vision and mission to carry this work forward.
Louis James de Viel Castel
Louis James de Viel Castel
Managing Director, Quilvest
Vice Chair for Programs
Senior Director, Medical and Scientific Affairs, Immune and Infectious Disease Franchise Qiagen
Vice Chair for Operations
Chairman, H&B Ågerup Foundation
Senior Managing Director, Ackman-Ziff Real Estate Group LLC
Physician, Pulmonary Medicine and Public Health
David A. Caputo
President Emeritus and Retired Professor of Political Science, Pace University
José Luis Castro (ex Officio)
President and Chief Executive Officer, Vital Strategies
Frank G. Colella
Attorney at Law
Dr. Mary-Ann Etiebet
Executive Director, Merck for Mothers
Roslyn “Roz” Feder
Biopharmaceutical Business Development Consultant
Dr. Lisa Fitzpatrick
Founder and CEO, Grapevine Health
President, Pendo LLC
Investor, Advisor and Board Member, Venture capital and private equity backed technology-enabled service businesses
President, Data-Mail, Inc.
President and CEO of Project Renewal
Medical Officer, Centers for Disease Control (Kenya)
Executive Vice President, Business Development, PharmaSphere
Neil W. Schluger (ex Officio)
Chief, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, Professor of Medicine, Epidemiology, and Environmental Health Sciences
Professor of Medicine, University of Illinois at Chicago, Section of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine